Find likely pipeline owners and technical buyers from public biopharma conference activity.

High — C-level, VP, or recognized thought leaders with direct budget or strategic influence.

Medium — Directors, senior managers, or functional leads who influence decisions but may not have final approval.

Low — Individual contributors, scientists, or specialists with domain expertise but limited purchasing authority.

Pipeline Owner - Biotech/Pharma — Leaders advancing programs and partnerships in biotech/pharma (not necessarily the final owner). May signal partnering or outsourcing intent.

Investor — VCs, corporate development, or fund managers evaluating assets or teams for funding/acquisition.

Service Provider / Vendor — CDMOs, CROs, consultants, or tool vendors who sell into the market rather than buy.

Other — Academic researchers, government officials, or roles that don't fit the above categories.

CxO — Chief Executive, Chief Scientific Officer, Chief Medical Officer, etc.

Executive Level — EVP, SVP, VP roles reporting to C-suite.

Senior Leadership — Heads of functions or divisions.

Middle Management — Directors and senior managers.

Team Lead — Managers leading small teams or projects.

Experienced Staff — Principal scientists, senior analysts, specialists.

Entry Level — Junior staff, interns, trainees.

Other — Unclassified or ambiguous titles.

Has Bio — Profile includes a biography or summary.

Has Speaking Session — Appeared in at least one conference session.

Has Articles — Published or cited in articles/publications.

Has Company Info — Linked to company profile with funding/industry data.

Has Business Intent Insight — Profile matches signals indicating active business intent or decision-making authority.